SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-152205
Filing Date
2021-12-21
Accepted
2021-12-21 16:30:30
Documents
12
Period of Report
2021-12-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2135883d2_8k.htm   iXBRL 8-K 32806
  Complete submission text file 0001104659-21-152205.txt   209664

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA cara-20211215.xsd EX-101.SCH 3049
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE cara-20211215_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cara-20211215_pre.xml EX-101.PRE 22375
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2135883d2_8k_htm.xml XML 3723
Mailing Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902
Business Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902 203-406-3700
Cara Therapeutics, Inc. (Filer) CIK: 0001346830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36279 | Film No.: 211509801
SIC: 2834 Pharmaceutical Preparations